Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Catalyst Biosciences Inc (CBIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011541
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Catalyst Biosciences Inc (Catalyst), formerly Targacept Inc is a clinical-stage biopharmaceutical company that develops novel medicines to address hematology indications. The company discovers and develops next generation biopharmaceuticals based on engineered human proteases platform technology. It concentrates on the development of products for hemostasis and anti-complement. Catalyst’s hemostasis product portfolio includes FVlla, FIX, and FXa; and anti-complement product portfolio comprises anti-C3, anti-C3, and anti-FB. The company’s products find application in the treatment of diseases such as hemophilia, macular degeneration, inflammation, myocardial ischemia, coronary artery bypass grafting and stroke. It operates through various international pharmaceutical companies to develop and commercialize its engineered human proteases. Catalyst is headquartered in South San Francisco, California, the US.

Catalyst Biosciences Inc (CBIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Catalyst Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Catalyst Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Catalyst Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Catalyst Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Catalyst Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Catalyst Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Catalyst Biosciences Raises Additional USD0.89 Million in Financing 10
Catalyst Biosciences Raises USD3.2 Million in Venture Financing 11
Catalyst Biosciences Raises US$5 Million In Venture Financing 12
Equity Offering 13
Catalyst Biosciences to Raise Funds through Public Offering of Shares 13
Catalyst Biosciences Raises USD20.7 Million in Public Offering of Units 14
Catalyst Biosciences Raises USD6.5 million in Public Offering of Shares 15
Debt Offering 16
Catalyst Biosciences Raises USD37 Million in Private Placement of Notes 16
Catalyst Biosciences Inc – Key Competitors 17
Catalyst Biosciences Inc – Key Employees 18
Catalyst Biosciences Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Nov 02, 2017: Catalyst Biosciences Reports Third Quarter 2017 Operating & Financial Results and Provides Corporate Update 20
May 11, 2017: Catalyst Biosciences Reports First Quarter 2017 Financial Results and Provides Corporate Update 21
Mar 08, 2017: Catalyst Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 22
Nov 03, 2016: Catalyst Biosciences Reports Third Quarter 2016 Financial Results and Provides Corporate Update 23
Aug 04, 2016: Catalyst Biosciences Reports Second Quarter 2016 Financial Results and Provides Corporate Update 24
Corporate Communications 25
Dec 14, 2017: Catalyst Biosciences Announces Appointment of Edward Williams to its Board of Directors 25
Nov 28, 2017: Catalyst Biosciences Strengthens Clinical Hemophilia Programs with Additions to its Senior Leadership Team 26
Feb 16, 2017: Catalyst Biosciences Announces Promotion of Andrew Hetherington to SVP of Technical Operations 27
Apr 18, 2016: Catalyst Biosciences Announces Appointments of Chief Medical Officer and Vice President of Business Development 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Catalyst Biosciences Inc, Medical Equipment, Key Facts, 2016 2
Catalyst Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Catalyst Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Catalyst Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Catalyst Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Catalyst Biosciences Inc, Deals By Market, 2011 to YTD 2017 8
Catalyst Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Catalyst Biosciences Raises Additional USD0.89 Million in Financing 10
Catalyst Biosciences Raises USD3.2 Million in Venture Financing 11
Catalyst Biosciences Raises US$5 Million In Venture Financing 12
Catalyst Biosciences to Raise Funds through Public Offering of Shares 13
Catalyst Biosciences Raises USD20.7 Million in Public Offering of Units 14
Catalyst Biosciences Raises USD6.5 million in Public Offering of Shares 15
Catalyst Biosciences Raises USD37 Million in Private Placement of Notes 16
Catalyst Biosciences Inc, Key Competitors 17
Catalyst Biosciences Inc, Key Employees 18

★海外企業調査レポート[Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Iridex Corp (IRIX):企業の財務・戦略的SWOT分析
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …
  • Osaka Gas Co Ltd (9532):電力:M&Aディール及び事業提携情報
    Summary Osaka Gas Co Ltd (OGCL) supplies natural gas to its customers in Kansai region, besides offering LPG, electricity and other energy-related products and services through affiliated enterprises. Its operations consist of domestic energy, environmental and non-energy, and international energy b …
  • Cub Energy Inc (KUB):企業の財務・戦略的SWOT分析
    Summary Cub Energy Inc (Cub Energy), formerly 3P International Energy Corp is an oil and gas company that explores and develops oil and gas assets in Ukraine. The company operates its oil and gas exploration assets in Transcarpathian Basin and Dnieper-Donets Basin. Cub Energy uses technologies such …
  • Rice Energy Inc.:企業のM&A・事業提携・投資動向
    Rice Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rice Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Provectus Biopharmaceuticals Inc (PVCT):企業の財務・戦略的SWOT分析
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Charles River Laboratories International Inc (CRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • Ardagh Group SA:戦略・SWOT・企業財務分析
    Ardagh Group SA - Strategy, SWOT and Corporate Finance Report Summary Ardagh Group SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Investment Technology Group, Inc.:企業の戦略・SWOT・財務分析
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • UCB S.A.:企業の戦略・SWOT・財務分析
    UCB S.A. - Strategy, SWOT and Corporate Finance Report Summary UCB S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Farbest-Tallman Foods Corp.:企業の戦略・SWOT・財務情報
    Farbest-Tallman Foods Corp. - Strategy, SWOT and Corporate Finance Report Summary Farbest-Tallman Foods Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • P2P Global Investments PLC (P2P):企業の財務・戦略的SWOT分析
    P2P Global Investments PLC (P2P) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PTC Inc.:企業の戦略・SWOT・財務情報
    PTC Inc. - Strategy, SWOT and Corporate Finance Report Summary PTC Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • LeMaitre Vascular Inc (LMAT)-医療機器分野:企業M&A・提携分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • Solvay Specialty Polymers Italy SpA:企業の戦略的SWOT分析
    Solvay Specialty Polymers Italy SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Roper Technologies Inc (ROP):企業の財務・戦略的SWOT分析
    Roper Technologies Inc (ROP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Maritz Holdings Inc.:企業の戦略的SWOT分析
    Maritz Holdings Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Strategic Oil & Gas Ltd (SOG):企業の財務・戦略的SWOT分析
    Summary Strategic Oil & Gas Ltd (Strategic Oil & Gas) is an upstream oil and gas exploration and development company. The company acquires, explores, operates, manages, and develops crude oil and natural gas assets. It holds interests and operates its oil and gas exploration projects such as Marlowe …
  • Arabia Insurance Cooperative Company:企業の戦略・SWOT・財務情報
    Arabia Insurance Cooperative Company - Strategy, SWOT and Corporate Finance Report Summary Arabia Insurance Cooperative Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Analogic Corp:企業の戦略的SWOT分析
    Analogic Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • TaiDoc Technology Corporation (4736):企業の財務・戦略的SWOT分析
    TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆